Feng A, Tan W, Xu W, Zhang X, Wei D, Yang Z. Genomic and Clinical Analysis of Influenza A in Hospitalized Adults, 2019-2024: Exploratory Evidence on Neuraminidase and Polymerase Acidic Protein Mutation-Outcome Associations From a Single Center. Influenza Other Respir Viruses. 2026 Nov;20(11):e7
Background: Antivirals are widely used to treat influenza, but potential resistance mutations remain a major challenge, and clinical data on key resistance mutations are limited.
Methods: We conducted a retrospective cohort study of 765 adults with RT-PCR-confirmed influenza A admitted to Ruijin Hospital, Shanghai, between 2019 and 2024 to determine whether specific NA/PA mutations are associated with severe outcomes or prolonged length of stay (LOS) when analyzed alongside key host factors. PA and NA sequences were obtained and linked to the clinical cohort for mutation-clinical outcome analyses. Multiple testing was addressed by controlling the false discovery rate using the Benjamini-Hochberg procedure.
Results: Among 765 inpatients with influenza A virus infection, the median age was 68 years; 5.0% were severe disease and 9.9% died. Older age, higher CURB-65 score, and bacterial/fungal co-infection were the main correlates of mortality, whereas antiviral regimen and Ct value were not independently associated with mortality or severe outcomes. Adjusted observational analyses showed a lower estimate for severe disease with baloxavir but no association with in-hospital death. Major high-level resistance mutations were absent; detected NA/PA mutations showed no robust association with severe disease or mortality. PA-F105L showed an exploratory association with longer LOS, but this finding was attenuated after adjustment and was confounded by clade and calendar period.
Conclusions: Clinical outcomes were driven mainly by host factors and admission severity. Detected NA/PA mutations were not robustly associated with severe outcomes, while high-level resistance could not be assessed; PA-F105L-LOS association requires phenotypic and external validation.
Methods: We conducted a retrospective cohort study of 765 adults with RT-PCR-confirmed influenza A admitted to Ruijin Hospital, Shanghai, between 2019 and 2024 to determine whether specific NA/PA mutations are associated with severe outcomes or prolonged length of stay (LOS) when analyzed alongside key host factors. PA and NA sequences were obtained and linked to the clinical cohort for mutation-clinical outcome analyses. Multiple testing was addressed by controlling the false discovery rate using the Benjamini-Hochberg procedure.
Results: Among 765 inpatients with influenza A virus infection, the median age was 68 years; 5.0% were severe disease and 9.9% died. Older age, higher CURB-65 score, and bacterial/fungal co-infection were the main correlates of mortality, whereas antiviral regimen and Ct value were not independently associated with mortality or severe outcomes. Adjusted observational analyses showed a lower estimate for severe disease with baloxavir but no association with in-hospital death. Major high-level resistance mutations were absent; detected NA/PA mutations showed no robust association with severe disease or mortality. PA-F105L showed an exploratory association with longer LOS, but this finding was attenuated after adjustment and was confounded by clade and calendar period.
Conclusions: Clinical outcomes were driven mainly by host factors and admission severity. Detected NA/PA mutations were not robustly associated with severe outcomes, while high-level resistance could not be assessed; PA-F105L-LOS association requires phenotypic and external validation.
See Also:
Latest articles in those days:
- Weekly US Influenza Surveillance Report: Key Updates for Week 45, ending November 14, 2026 11 hours ago
- Anatomical Compartmentalization in Chickens Drives Divergent H9N2 Influenza Evolution Toward Human Receptor Binding and Immune Escape 1 days ago
- Epidemiologic Variability and Clinical Severity Across 11 Influenza Seasons in Children 2 days ago
- Molecular Epidemiology of Clade 2.3.4.4b H5N1 High-Pathogenicity Avian Influenza in South Africa, 2025-2026 2 days ago
- Structural basis of avian-to-human receptor-binding adaptation in H9Ny influenza A virus hemagglutinin 2 days ago
[Go Top] [Close Window]


